SCHEMBL30097060

SCHEMBL30097060

O=C(O)c1cc2c(Br)cccc2[nH]1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.58
KDM4E B2RXH2 3/20 0.57
HSD17B10 Q99714 3/20 0.57
ALDH1A1 P00352 2/20 0.57
HPGD P15428 2/20 0.57
GRIN1 Q05586 2/20 0.57
HRH4 Q9H3N8 1/20 0.57
MEN1 O00255 1/20 0.57
GRIN2D O15399 1/20 0.57
GRIN3B O60391 1/20 0.57
CYP1A2 P05177 1/20 0.57
GLA P06280 1/20 0.57
GAA P10253 1/20 0.57
MAPK1 P28482 1/20 0.57
CYP2C19 P33261 1/20 0.57
AHR P35869 1/20 0.57
CHRNA7 P36544 1/20 0.57
KMT2A Q03164 1/20 0.57
GRIN2A Q12879 1/20 0.57
GRIN2B Q13224 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145350 1.00 FLT3 (0.58) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL30295665 0.84 FLT3 (0.57) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL924331 0.84 FLT3 (0.57) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL19625090 0.80 FLT3 (0.53) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL2205092 0.80 HRH4 (0.56) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL31414534 0.80 HRH4 (0.56) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL1076712 0.80 HRH4 (0.56) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL2806087 0.80 KDM4E (0.59) KDM4EHSD17B10ALDH1A1HPGDGRIN1
SCHEMBL2762336 0.80 KDM4E (0.59) FLT3KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL3417091 0.80 FLT3 (0.60) FLT3KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149459-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV Pharmaceuticals, Inc. (US) 2023-03-22 EP disclosed
EP-4096667-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed